We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
story of the week

Journal Scan / Research · January 20, 2022

Active Surveillance vs Immediate Systemic Treatment in Metastatic Renal Cell Carcinoma

Clinical Genitourinary Cancer

 

Additional Info

Disclosure statements are available on the authors' profiles:

Clinical Genitourinary Cancer
Active Surveillance in Metastatic Renal Cell Carcinoma: Results From the Canadian Kidney Cancer Information System
Clin Genitourin Cancer 2021 Dec 01;19(6)P521-530, I Kushnir, NS Basappa, S Ghosh, et al

Further Reading